1
Home
Companies

CNS Pharmaceutical

CNS Pharmaceutical
Leadership team

Mr. John Michael Climaco Esq., J.D. (Chairman, CEO & Pres)

Mr. Christopher S. Downs CPA, CTP, FP&A (Chief Financial Officer)

Dr. Sandra L. Silberman M.D., Ph.D. (Chief Medical Officer)

Products/ Services
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Number of Employees
0 - 50
Headquarters
Houston, Texas, United States
Established
2017
Company Registration
SEC CIK number: 0001729427
Traded as
NASDAQ:CNSP
Social Media
URL
https://www.cnspharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas.
History

CNS Pharmaceuticals was established in 2015 as a brain cancer focused biotech company. They have raised nearly $2.5m in venture capital and completed promising Phase 1 clinical trials.

Mission
Our mission is to develop novel therapies and treatments for primary and metastatic brain cancer, so that patients with this devastating disease can have more effective options in a shorter time frame.
Vision
Our vision is to be the leader in brain cancer drug development, with an extensive portfolio of treatments that have improved outcomes and reduced time to market.
Key Team

Dr. Waldemar Priebe Ph.D. (Founder)

Dr. Donald H. Picker Ph.D. (Chief Science Officer)

Recognition and Awards
CNS Pharmaceuticals has received several awards from investors and industry, including the Biotech Investment of the Year at the 2016 National Biotech Awards.
References

https://in.investing.com/equities/cns-pharmaceuticals-inc

https://finance.yahoo.com/quote/CNSP/profile?p=CNSP

https://www.crunchbase.com/organization/cns-pharmaceutical#:~:text=CNS%20Pharmaceuticals%20is%20a%20pre,and%20ovarian%20cancers%20and%20lymphoma.

https://www.cnspharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

CNS Pharmaceutical
Leadership team

Mr. John Michael Climaco Esq., J.D. (Chairman, CEO & Pres)

Mr. Christopher S. Downs CPA, CTP, FP&A (Chief Financial Officer)

Dr. Sandra L. Silberman M.D., Ph.D. (Chief Medical Officer)

Products/ Services
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Number of Employees
0 - 50
Headquarters
Houston, Texas, United States
Established
2017
Company Registration
SEC CIK number: 0001729427
Traded as
NASDAQ:CNSP
Social Media
URL
https://www.cnspharma.com